|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$29.97 |
$30.95 |
$29.42 |
$30.17 |
697.60K | 03/22/2024 |
$30.20 |
$30.46 |
$29.05 |
$29.09 |
462.80K | 03/25/2024 |
$29.00 |
$29.76 |
$28.29 |
$28.86 |
363.80K | 03/26/2024 |
$29.38 |
$29.47 |
$27.92 |
$27.96 |
631.40K | 03/27/2024 |
$28.18 |
$29.85 |
$27.91 |
$29.44 |
436.90K |
|
PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of medicines. Co. has a portfolio pipeline that includes several commercial products and product candidates focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology, metabolism and oncology. Co. has two products, Translarna (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, or DMD. Translarna is designed for the treatment of nonsense mutation DMD in ambulatory patients aged two years and older Emflaza is designed for the treatment of DMD in patients two years and older. | |
|
PTC Therapeutics (PTCT) has the following price history information. Looking back at PTCT historical stock prices for the last five trading days, on March 21, 2024, PTCT opened at $29.97, traded as high as $30.95 and as low as $29.42, and closed at $30.17. Trading volume was a total of 697.60K shares. On March 22, 2024, PTCT opened at $30.20, traded as high as $30.46 and as low as $29.05, and closed at $29.09. Trading volume was a total of 462.80K shares. On March 25, 2024, PTCT opened at $29.00, traded as high as $29.76 and as low as $28.29, and closed at $28.86. Trading volume was a total of 363.80K shares. On March 26, 2024, PTCT opened at $29.38, traded as high as $29.47 and as low as $27.92, and closed at $27.96. Trading volume was a total of 631.40K shares. On March 27, 2024, PTCT opened at $28.18, traded as high as $29.85 and as low as $27.91, and closed at $29.44. Trading volume was a total of 436.90K shares.
PTCT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into PTC Therapeutics shares, starting with a $10,000 purchase of PTCT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$26.14 |
|
End price/share: |
$29.44 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
12.62% |
|
Average Annual Total Return: |
1.20% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$11,266.55 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $30.17 | 03/22/2024 | $29.09 | 03/25/2024 | $28.86 | 03/26/2024 | $27.96 | 03/27/2024 | $29.44 |
|
|